Quick Heal Technologies (NSE: QUICKHEAL) saw its stock decline by 8.72% to ₹694.95 as of 9:24 AM, following the announcement of its Q2 FY25 results. The stock opened at ₹732.40, reached a high of ₹734.15, and a low of ₹678.65, with the previous close at ₹761.35.
Despite strong H1 FY25 financials, which saw an 11% year-on-year revenue growth and a 238% increase in EBITDA, investor sentiment turned negative due to concerns over the company’s Q2 performance. Quick Heal had recently announced the launch of AntiFraud.AI, India’s first consumer fraud prevention solution, and reported impressive growth in both its consumer and enterprise verticals.
However, the stock market reacted to the broader outlook in Q2, where growth in some areas was perceived as slower than expected. Analysts are waiting for more detailed insights into the company’s Q2 breakdown to understand the performance variance.
Despite the short-term stock decline, Quick Heal’s long-term strategy, with a strong focus on innovation and expansion of its cybersecurity solutions, remains intact. The company continues to innovate, launching new products like AntiFraud.AI and enhancing its presence in the digital security domain.
Disclaimer: The information provided in this article is for informational purposes only and should not be construed as investment advice. Please seek independent financial advice before making any investment decisions.
